AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19
NCT04516759
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
170
Enrollment
OTHER
Sponsor class
Conditions
Covid19
Interventions
DRUG:
AZD1656
OTHER:
Placebo
Sponsor
St George Street Capital